Home/Filings/4/0001628280-25-028890
4//SEC Filing

Farid Ramy 4

Accession 0001628280-25-028890

CIK 0001706431other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 7:19 PM ET

Size

271.3 KB

Accession

0001628280-25-028890

Insider Transaction Report

Form 4
Period: 2025-05-30
Farid Ramy
Director
Transactions
  • Award

    Common Stock

    2025-05-30+8,00024,000 total
  • Award

    Stock Option (Right to Buy)

    2025-05-30+16,00016,000 total
    Exercise: $4.94From: 2026-05-30Exp: 2035-05-29Common Stock (16,000 underlying)
Footnotes (3)
  • [F1]Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • [F2]The RSUs will vest in full on May 30, 2026.
  • [F3]The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0001797707

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:19 PM ET
Size
271.3 KB